Ben Mosbah Ismail, Roselló-Catafau Joan, Franco-Gou Rosa, Abdennebi Hassen Ben, Saidane Dalila, Ramella-Virieux Silvina, Boillot Olivier, Peralta Carmen
Department of Experimental Pathology, Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas, Institut d'Investigacions Biomèdiques August Pí i Sunyer, Barcelona, Spain.
Liver Transpl. 2006 Aug;12(8):1215-23. doi: 10.1002/lt.20788.
A new Institut Georges Lopez (IGL-1) solution was used to preserve steatotic livers. Steatotic (obese [Ob]) and nonsteatotic (lean [Ln]) livers from Zücker rats (n = 16, 8 Ln and 8 Ob) were preserved for 24 hours at 4 degrees C in University of Wisconsin (UW) or IGL-1 solution, respectively, and then perfused ex vivo for 2 hours at 37 degrees C. Additionally, Ob and Ln livers (n = 16, 8 Ln and 8 Ob) were preserved in IGL-1 plus Nomega-nitro-L-arginine methyl ester hydrochloride (L-NAME). Hepatic injury and function (aminotransferases, bile production, bromosulfophthalein clearance), and factors potentially involved in the susceptibility of steatotic livers to ischemia-reperfusion injury, such as oxidative stress, mitochondrial damage, and vascular resistance, were studied. Nitric oxide (NO) production and constitutive and inducible NO synthase were also measured. Steatotic and nonsteatotic livers preserved in IGL-1 solution showed lower transaminases, malondialdehyde, glutamate dehydrogenase levels, and higher bile production than UW-solution-preserved livers. IGL-1 solution protected against oxidative stress, mitochondrial damage and the alterations in vascular resistance associated with cold ischemia-reperfusion. Thus, at the end of reperfusion period, aspartate aminotransferase levels in steatotic livers were 281 +/- 6 U/L in UW vs. 202 +/- 10 U/L in IGL-1 solution. Glutamate dehydrogenase was 463 +/- 75 U/L in UW vs. 111 +/- 4 U/L in IGL-1 solution, and oxidative stress was 3.0 +/- 0.1 nmol/mg prot in UW vs. 2.0 +/- 0.1 nmol/mg prot in IGL-1 solution. These beneficial effects of IGL-1 solution were abolished by the addition of L-NAME, which implicates NO in the benefits of IGL-1. In conclusion, IGL-1 solution provided steatotic livers with better protection against the deleterious effects of cold ischemia-reperfusion injury than did UW solution.
一种新的乔治·洛佩斯研究所(IGL-1)溶液被用于保存脂肪变性肝脏。将来自 Zucker 大鼠的脂肪变性(肥胖[Ob])和非脂肪变性(瘦[Ln])肝脏(n = 16,8 个 Ln 和 8 个 Ob)分别在 4℃下于威斯康星大学(UW)溶液或 IGL-1 溶液中保存 24 小时,然后在 37℃下进行 2 小时的离体灌注。此外,Ob 和 Ln 肝脏(n = 16,8 个 Ln 和 8 个 Ob)保存在 IGL-1 加盐酸 Nω-硝基-L-精氨酸甲酯(L-NAME)中。研究了肝损伤和功能(转氨酶、胆汁生成、溴磺酚酞清除率),以及可能参与脂肪变性肝脏对缺血再灌注损伤易感性的因素,如氧化应激、线粒体损伤和血管阻力。还测量了一氧化氮(NO)生成以及组成型和诱导型 NO 合酶。与 UW 溶液保存的肝脏相比,保存在 IGL-1 溶液中的脂肪变性和非脂肪变性肝脏显示出更低的转氨酶、丙二醛、谷氨酸脱氢酶水平以及更高的胆汁生成。IGL-1 溶液可防止氧化应激、线粒体损伤以及与冷缺血再灌注相关的血管阻力改变。因此,在再灌注期结束时,UW 溶液保存的脂肪变性肝脏中天冬氨酸转氨酶水平为 281±6 U/L,而 IGL-1 溶液中为 202±10 U/L。UW 溶液中谷氨酸脱氢酶为 463±75 U/L,IGL-1 溶液中为 111±4 U/L,氧化应激在 UW 溶液中为 3.0±0.1 nmol/mg 蛋白,IGL-1 溶液中为 2.0±0.1 nmol/mg 蛋白。添加 L-NAME 消除了 IGL-1 溶液的这些有益作用,这表明 NO 在 IGL-1 的益处中起作用。总之,与 UW 溶液相比,IGL-1 溶液为脂肪变性肝脏提供了更好的保护,使其免受冷缺血再灌注损伤的有害影响。